91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Plasmid DNA CDMO Service Market Growth (Status and Outlook) 2024-2030

Global Plasmid DNA CDMO Service Market Growth (Status and Outlook) 2024-2030

Publication ID: 
LPI10249404
Publication Date: 
October 14, 2024
Pages: 
128
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

IT Services [2]
Software [3]
Computing & Electronics [4]
Description: 

Plasmid DNA CDMO (Contract Development and Manufacturing Organization) services involve providing specialized support for the development, production, and commercialization of plasmid DNA used in biopharmaceutical applications. These services cater to the growing demand for plasmid DNA, which plays a crucial role in gene therapy, cell therapy, vaccines, and other biotechnological advancements.
The global Plasmid DNA CDMO Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the 鈥淧lasmid DNA CDMO Service Industry Forecast鈥� looks at past sales and reviews total world Plasmid DNA CDMO Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Plasmid DNA CDMO Service sales for 2023 through 2029. With Plasmid DNA CDMO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasmid DNA CDMO Service industry.
This Insight Report provides a comprehensive analysis of the global Plasmid DNA CDMO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Plasmid DNA CDMO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Plasmid DNA CDMO Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasmid DNA CDMO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasmid DNA CDMO Service.
United States market for Plasmid DNA CDMO Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Plasmid DNA CDMO Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Plasmid DNA CDMO Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Plasmid DNA CDMO Service players cover Creative Biogene, AGC Biologics, Biovian, GenScript ProBio, Charles River Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasmid DNA CDMO Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Research Grade
Commercial Grade
GMP Grade
Others
Segmentation by Application:
Preclinical
Clinical
Commercial
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Research Grade
Commercial Grade
GMP Grade
Others
Segmentation by Application:
Preclinical
Clinical
Commercial
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biogene
AGC Biologics
Biovian
GenScript ProBio
Charles River Laboratories
PackGene
Catalent Biologics
Patheon
Mycenax Biotech Inc
VGXI
Esco Aster
Eurogentec
53Biologics
SK pharmteco
Cytovance Biologics
Aldevron
Bionova Scientific

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasmid DNA CDMO Service Market Size 2019-2030
2.1.2 Plasmid DNA CDMO Service Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Plasmid DNA CDMO Service by Country/Region, 2019, 2023 & 2030
2.2 Plasmid DNA CDMO Service Segment by Type
2.2.1 Research Grade
2.2.2 Commercial Grade
2.2.3 GMP Grade
2.2.4 Others
2.3 Plasmid DNA CDMO Service Market Size by Type
2.3.1 Plasmid DNA CDMO Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Plasmid DNA CDMO Service Market Size Market Share by Type (2019-2024)
2.4 Plasmid DNA CDMO Service Segment by Application
2.4.1 Preclinical
2.4.2 Clinical
2.4.3 Commercial
2.5 Plasmid DNA CDMO Service Market Size by Application
2.5.1 Plasmid DNA CDMO Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Plasmid DNA CDMO Service Market Size Market Share by Application (2019-2024)
3 Plasmid DNA CDMO Service Market Size by Player
3.1 Plasmid DNA CDMO Service Market Size Market Share by Player
3.1.1 Global Plasmid DNA CDMO Service Revenue by Player (2019-2024)
3.1.2 Global Plasmid DNA CDMO Service Revenue Market Share by Player (2019-2024)
3.2 Global Plasmid DNA CDMO Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Plasmid DNA CDMO Service by Region
4.1 Plasmid DNA CDMO Service Market Size by Region (2019-2024)
4.2 Global Plasmid DNA CDMO Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas Plasmid DNA CDMO Service Market Size Growth (2019-2024)
4.4 APAC Plasmid DNA CDMO Service Market Size Growth (2019-2024)
4.5 Europe Plasmid DNA CDMO Service Market Size Growth (2019-2024)
4.6 Middle East & Africa Plasmid DNA CDMO Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas Plasmid DNA CDMO Service Market Size by Country (2019-2024)
5.2 Americas Plasmid DNA CDMO Service Market Size by Type (2019-2024)
5.3 Americas Plasmid DNA CDMO Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasmid DNA CDMO Service Market Size by Region (2019-2024)
6.2 APAC Plasmid DNA CDMO Service Market Size by Type (2019-2024)
6.3 APAC Plasmid DNA CDMO Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Plasmid DNA CDMO Service Market Size by Country (2019-2024)
7.2 Europe Plasmid DNA CDMO Service Market Size by Type (2019-2024)
7.3 Europe Plasmid DNA CDMO Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plasmid DNA CDMO Service by Region (2019-2024)
8.2 Middle East & Africa Plasmid DNA CDMO Service Market Size by Type (2019-2024)
8.3 Middle East & Africa Plasmid DNA CDMO Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Plasmid DNA CDMO Service Market Forecast
10.1 Global Plasmid DNA CDMO Service Forecast by Region (2025-2030)
10.1.1 Global Plasmid DNA CDMO Service Forecast by Region (2025-2030)
10.1.2 Americas Plasmid DNA CDMO Service Forecast
10.1.3 APAC Plasmid DNA CDMO Service Forecast
10.1.4 Europe Plasmid DNA CDMO Service Forecast
10.1.5 Middle East & Africa Plasmid DNA CDMO Service Forecast
10.2 Americas Plasmid DNA CDMO Service Forecast by Country (2025-2030)
10.2.1 United States Market Plasmid DNA CDMO Service Forecast
10.2.2 Canada Market Plasmid DNA CDMO Service Forecast
10.2.3 Mexico Market Plasmid DNA CDMO Service Forecast
10.2.4 Brazil Market Plasmid DNA CDMO Service Forecast
10.3 APAC Plasmid DNA CDMO Service Forecast by Region (2025-2030)
10.3.1 China Plasmid DNA CDMO Service Market Forecast
10.3.2 Japan Market Plasmid DNA CDMO Service Forecast
10.3.3 Korea Market Plasmid DNA CDMO Service Forecast
10.3.4 Southeast Asia Market Plasmid DNA CDMO Service Forecast
10.3.5 India Market Plasmid DNA CDMO Service Forecast
10.3.6 Australia Market Plasmid DNA CDMO Service Forecast
10.4 Europe Plasmid DNA CDMO Service Forecast by Country (2025-2030)
10.4.1 Germany Market Plasmid DNA CDMO Service Forecast
10.4.2 France Market Plasmid DNA CDMO Service Forecast
10.4.3 UK Market Plasmid DNA CDMO Service Forecast
10.4.4 Italy Market Plasmid DNA CDMO Service Forecast
10.4.5 Russia Market Plasmid DNA CDMO Service Forecast
10.5 Middle East & Africa Plasmid DNA CDMO Service Forecast by Region (2025-2030)
10.5.1 Egypt Market Plasmid DNA CDMO Service Forecast
10.5.2 South Africa Market Plasmid DNA CDMO Service Forecast
10.5.3 Israel Market Plasmid DNA CDMO Service Forecast
10.5.4 Turkey Market Plasmid DNA CDMO Service Forecast
10.6 Global Plasmid DNA CDMO Service Forecast by Type (2025-2030)
10.7 Global Plasmid DNA CDMO Service Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Plasmid DNA CDMO Service Forecast
11 Key Players Analysis
11.1 Creative Biogene
11.1.1 Creative Biogene Company Information
11.1.2 Creative Biogene Plasmid DNA CDMO Service Product Offered
11.1.3 Creative Biogene Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Creative Biogene Main Business Overview
11.1.5 Creative Biogene Latest Developments
11.2 AGC Biologics
11.2.1 AGC Biologics Company Information
11.2.2 AGC Biologics Plasmid DNA CDMO Service Product Offered
11.2.3 AGC Biologics Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AGC Biologics Main Business Overview
11.2.5 AGC Biologics Latest Developments
11.3 Biovian
11.3.1 Biovian Company Information
11.3.2 Biovian Plasmid DNA CDMO Service Product Offered
11.3.3 Biovian Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Biovian Main Business Overview
11.3.5 Biovian Latest Developments
11.4 GenScript ProBio
11.4.1 GenScript ProBio Company Information
11.4.2 GenScript ProBio Plasmid DNA CDMO Service Product Offered
11.4.3 GenScript ProBio Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GenScript ProBio Main Business Overview
11.4.5 GenScript ProBio Latest Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Information
11.5.2 Charles River Laboratories Plasmid DNA CDMO Service Product Offered
11.5.3 Charles River Laboratories Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Charles River Laboratories Main Business Overview
11.5.5 Charles River Laboratories Latest Developments
11.6 PackGene
11.6.1 PackGene Company Information
11.6.2 PackGene Plasmid DNA CDMO Service Product Offered
11.6.3 PackGene Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 PackGene Main Business Overview
11.6.5 PackGene Latest Developments
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Information
11.7.2 Catalent Biologics Plasmid DNA CDMO Service Product Offered
11.7.3 Catalent Biologics Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Catalent Biologics Main Business Overview
11.7.5 Catalent Biologics Latest Developments
11.8 Patheon
11.8.1 Patheon Company Information
11.8.2 Patheon Plasmid DNA CDMO Service Product Offered
11.8.3 Patheon Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Patheon Main Business Overview
11.8.5 Patheon Latest Developments
11.9 Mycenax Biotech Inc
11.9.1 Mycenax Biotech Inc Company Information
11.9.2 Mycenax Biotech Inc Plasmid DNA CDMO Service Product Offered
11.9.3 Mycenax Biotech Inc Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mycenax Biotech Inc Main Business Overview
11.9.5 Mycenax Biotech Inc Latest Developments
11.10 VGXI
11.10.1 VGXI Company Information
11.10.2 VGXI Plasmid DNA CDMO Service Product Offered
11.10.3 VGXI Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 VGXI Main Business Overview
11.10.5 VGXI Latest Developments
11.11 Esco Aster
11.11.1 Esco Aster Company Information
11.11.2 Esco Aster Plasmid DNA CDMO Service Product Offered
11.11.3 Esco Aster Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Esco Aster Main Business Overview
11.11.5 Esco Aster Latest Developments
11.12 Eurogentec
11.12.1 Eurogentec Company Information
11.12.2 Eurogentec Plasmid DNA CDMO Service Product Offered
11.12.3 Eurogentec Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Eurogentec Main Business Overview
11.12.5 Eurogentec Latest Developments
11.13 53Biologics
11.13.1 53Biologics Company Information
11.13.2 53Biologics Plasmid DNA CDMO Service Product Offered
11.13.3 53Biologics Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 53Biologics Main Business Overview
11.13.5 53Biologics Latest Developments
11.14 SK pharmteco
11.14.1 SK pharmteco Company Information
11.14.2 SK pharmteco Plasmid DNA CDMO Service Product Offered
11.14.3 SK pharmteco Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 SK pharmteco Main Business Overview
11.14.5 SK pharmteco Latest Developments
11.15 Cytovance Biologics
11.15.1 Cytovance Biologics Company Information
11.15.2 Cytovance Biologics Plasmid DNA CDMO Service Product Offered
11.15.3 Cytovance Biologics Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Cytovance Biologics Main Business Overview
11.15.5 Cytovance Biologics Latest Developments
11.16 Aldevron
11.16.1 Aldevron Company Information
11.16.2 Aldevron Plasmid DNA CDMO Service Product Offered
11.16.3 Aldevron Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Aldevron Main Business Overview
11.16.5 Aldevron Latest Developments
11.17 Bionova Scientific
11.17.1 Bionova Scientific Company Information
11.17.2 Bionova Scientific Plasmid DNA CDMO Service Product Offered
11.17.3 Bionova Scientific Plasmid DNA CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Bionova Scientific Main Business Overview
11.17.5 Bionova Scientific Latest Developments
12 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-plasmid-dna-cdmo-service-market-growth-status-and-outlook-2024-2030

Links
[1] /countries/global[2] /it-services[3] /software[4] /computing-electronics